Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AtriCure, Inc. - Common Stock (NQ:ATRC)

39.00 +2.69 (+7.41%)
Streaming Delayed Price Updated: 12:31 PM EST, Dec 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about AtriCure, Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
AtriCure to Participate in the Piper Sandler 37th Annual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Third Quarter 2025 Financial Results; Raises Financial Outlook for 2025
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces the First Patient Treated in the BoxX-NoAF Clinical Trial
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in Upcoming Investor Conferences
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Third Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces the Launch of the cryoXT™ Device for Post-Operative Pain Management Following Amputation
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the 2025 Wells Fargo Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Second Quarter 2025 Financial Results; Raises Financial Outlook for 2025
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the Canaccord Genuity 45th Annual Growth Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Completes Enrollment in LeAAPS Clinical Trial for Stroke Prevention
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Second Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports First Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces First Use of the AtriClip PRO-Mini® Device
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce First Quarter 2025 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Host Analyst & Investor Day on March 26, 2025
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the Stifel 2024 Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Third Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure to Participate in the UBS Global Healthcare Conference
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
From AtriCure
Via Business Wire
News headline image
AtriCure to Announce Third Quarter 2024 Financial Results
From AtriCure, Inc
Via Business Wire
News headline image
AtriCure Receives CE-Mark for the EnCompass® Clamp
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation
From AtriCure, Inc.
Via Business Wire
News headline image
AtriCure Reports Second Quarter 2024 Financial Results
From AtriCure, Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.